- Home
- LSBK vs ACOG Comparison
LSBK vs ACOG Comparison
Compare LSBK & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSBK
- ACOG
- Stock Information
- Founded
- LSBK 1891
- ACOG 2000
- Country
- LSBK United States
- ACOG Canada
- Employees
- LSBK N/A
- ACOG N/A
- Industry
- LSBK Savings Institutions
- ACOG
- Sector
- LSBK Finance
- ACOG
- Exchange
- LSBK Nasdaq
- ACOG Nasdaq
- Market Cap
- LSBK 90.0M
- ACOG 80.3M
- IPO Year
- LSBK 2006
- ACOG N/A
- Fundamental
- Price
- LSBK $15.85
- ACOG $10.80
- Analyst Decision
- LSBK
- ACOG Strong Buy
- Analyst Count
- LSBK 0
- ACOG 1
- Target Price
- LSBK N/A
- ACOG $20.00
- AVG Volume (30 Days)
- LSBK 6.0K
- ACOG 67.2K
- Earning Date
- LSBK 07-23-2025
- ACOG 08-14-2025
- Dividend Yield
- LSBK 3.39%
- ACOG N/A
- EPS Growth
- LSBK 27.62
- ACOG N/A
- EPS
- LSBK 0.89
- ACOG N/A
- Revenue
- LSBK $25,795,000.00
- ACOG $2,928,654.00
- Revenue This Year
- LSBK N/A
- ACOG N/A
- Revenue Next Year
- LSBK N/A
- ACOG N/A
- P/E Ratio
- LSBK $17.83
- ACOG N/A
- Revenue Growth
- LSBK N/A
- ACOG N/A
- 52 Week Low
- LSBK $11.85
- ACOG $3.75
- 52 Week High
- LSBK $16.95
- ACOG $11.54
- Technical
- Relative Strength Index (RSI)
- LSBK 50.07
- ACOG N/A
- Support Level
- LSBK $15.22
- ACOG N/A
- Resistance Level
- LSBK $16.20
- ACOG N/A
- Average True Range (ATR)
- LSBK 0.15
- ACOG 0.00
- MACD
- LSBK -0.02
- ACOG 0.00
- Stochastic Oscillator
- LSBK 55.11
- ACOG 0.00
About LSBK Lake Shore Bancorp Inc.
Lake Shore Bancorp Inc operates as a savings and loan holdings company. The bank's business consists of attracting retail deposits from the general public in the areas surrounding its branch offices and investing those deposits, together with funds generated from operations, in commercial real estate loans, one-to-four family residential mortgage loans, home equity lines of credit and to a lesser extent, commercial business loans, consumer loans, and investment securities. Its revenues are principally derived from interest earned on loans and investment securities.
About ACOG Alpha Cognition Inc. Common Stock
Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.